NCT01704404View on ClinicalTrials.gov

7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

62

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions

COPD

Interventions

DRUG

TD-4208

DRUG

Placebo

Trial Locations (1)

Unknown

P3 Research Ltd, Wellington

Sponsors

Lead Sponsor

Collaborators (1)

Theravance Biopharma

All Listed Sponsors

collaborator

Theravance Biopharma

INDUSTRY

lead

Mylan Inc.

INDUSTRY